Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Carlomagno

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
European Thyroid Journal|May 1, 2014
Thyroid Cancer: Role of RET and BeyondFrancesca Carlomagno
Current Medicinal Chemistry|July 21, 2005
Receptor tyrosine kinases as targets for anticancer therapeuticsFrancesca Carlomagno, Massimo Santoro
The Journal of Clinical Investigation|October 29, 2013
Oncogenic rearrangements driving ionizing radiation-associated human cancerMassimo Santoro, Francesca Carlomagno
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancerMassimo Santoro, Francesca Carlomagno
Cold Spring Harbor Perspectives in Biology|December 4, 2013
Central role of RET in thyroid cancerMassimo Santoro, Francesca Carlomagno
Journal of Molecular Medicine (Berlin, Germany)|June 8, 2014
Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapyFrancesca Carlomagno, Mario Chiariello
Advances in Experimental Medicine and Biology|July 2, 2025
Iron and Cell DeathGiorgia Federico, Marialuisa Moccia, Francesca Carlomagno
Genes|April 25, 2020
RET Gene Fusions in Malignancies of the Thyroid and Other TissuesMassimo Santoro, Marialuisa Moccia, Giorgia Federico, et al.
Endocrine-Related Cancer|October 16, 2024
Mechanisms of RET-mediated signal transductionFrancesca Carlomagno, Marialuisa Moccia, Giorgia Federico, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Receptor tyrosine kinase inhibitors in thyroid cancerMaria Domenica Castellone, Francesca Carlomagno, Giuliana Salvatore, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
European Thyroid Journal|May 1, 2014
Thyroid Cancer: Role of RET and BeyondFrancesca Carlomagno
Current Medicinal Chemistry|July 21, 2005
Receptor tyrosine kinases as targets for anticancer therapeuticsFrancesca Carlomagno, Massimo Santoro
The Journal of Clinical Investigation|October 29, 2013
Oncogenic rearrangements driving ionizing radiation-associated human cancerMassimo Santoro, Francesca Carlomagno
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancerMassimo Santoro, Francesca Carlomagno
Cold Spring Harbor Perspectives in Biology|December 4, 2013
Central role of RET in thyroid cancerMassimo Santoro, Francesca Carlomagno
Journal of Molecular Medicine (Berlin, Germany)|June 8, 2014
Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapyFrancesca Carlomagno, Mario Chiariello
Advances in Experimental Medicine and Biology|July 2, 2025
Iron and Cell DeathGiorgia Federico, Marialuisa Moccia, Francesca Carlomagno
Genes|April 25, 2020
RET Gene Fusions in Malignancies of the Thyroid and Other TissuesMassimo Santoro, Marialuisa Moccia, Giorgia Federico, et al.
Endocrine-Related Cancer|October 16, 2024
Mechanisms of RET-mediated signal transductionFrancesca Carlomagno, Marialuisa Moccia, Giorgia Federico, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Receptor tyrosine kinase inhibitors in thyroid cancerMaria Domenica Castellone, Francesca Carlomagno, Giuliana Salvatore, et al.
Pageof 7